Neuralink, the brain implant company founded by Tesla's (NASDAQ:TSLA) Elon Musk, said it will begin a feasibility study to determine if its N1 Implant can be used to control an investigational ...

Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant technology. This latest financial boost is aimed at expanding the reach of the ...

Elon Musk’s brain-implant company Neuralink has chosen the Barrow Neurological Institute in Phoenix, Arizona, as the initial study site to test its Telepathy device. The first participant in ...

In a livestreamed update on X, Elon Musk and Neuralink executives gave an update on the company's next study participant—and its next-generation brain implant. A second person will soon receive ...

Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients ...

Neuralink is launching a trial to see if patients can use its brain implant can control a robot arm. Elon Musk's company said the study was a step toward "not only digital freedom, but physical ...

The third human to receive a Neuralink brain implant, who also has non-verbal ... "They each volunteered to participate in Neuralink’s PRIME Study, a clinical trial to demonstrate that the ...

Paradromics implanted its first brain implant device, Connexus, in a human patient last month, successfully recording electrical signals from individual neurons.

Neuralink says it has successfully implanted another brain chip in a human patient. According to a study update shared ... At the time, Musk said 400 of the implant's electrodes on the second ...

Elon Musk's brain technology startup Neuralink said on Monday it has received approval to launch a new feasibility study using its brain implant and an experimental robotic arm. Neuralink is ...

The third human to receive a Neuralink brain implant, who also has non-verbal ... "They each volunteered to participate in Neuralink’s PRIME Study, a clinical trial to demonstrate that the ...